2022
DOI: 10.1016/j.nrl.2022.03.007
|View full text |Cite
|
Sign up to set email alerts
|

Post-COVID-19 memory complaints: Prevalence and associated factors

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 38 publications
1
3
0
Order By: Relevance
“…The neurological manifestations of post‐COVID‐19 are increasingly reported in literatures; however, with diverse prevalences and risk factors associated with memory impairment. The prevalence of memory deficit in this study was 34.5% that was comparable to studies from France (34%), 22 Netherland (33%), 23 and Italy (31%), 24 while it was higher than studies from Bangladesh (19.2%) 25 and Norway (11%) 26 . The relatively high prevalence rate in our study could be attributed to the inclusion of both hospitalized and nonhospitalized patients.…”
Section: Discussionsupporting
confidence: 69%
See 1 more Smart Citation
“…The neurological manifestations of post‐COVID‐19 are increasingly reported in literatures; however, with diverse prevalences and risk factors associated with memory impairment. The prevalence of memory deficit in this study was 34.5% that was comparable to studies from France (34%), 22 Netherland (33%), 23 and Italy (31%), 24 while it was higher than studies from Bangladesh (19.2%) 25 and Norway (11%) 26 . The relatively high prevalence rate in our study could be attributed to the inclusion of both hospitalized and nonhospitalized patients.…”
Section: Discussionsupporting
confidence: 69%
“…This finding was concordant with result of other literatures, 32 whereas, others did not note such a finding. 3,25 Generally, older age patients have increased concomitant comorbid diseases, hence an increased risk of severe COVID-19 and consequently post-COVID-19 memory impairment.…”
Section: Discussionmentioning
confidence: 99%
“… 1 As the number of severe cases declines, it becomes imperative to anticipate and mitigate potential long-term consequences in individuals who have recovered from SARS-CoV-2 infection. Notably, a range of manifestations have been documented as sequelae thus far, including encephalitis, 2 , 3 , 4 , 5 memory loss, 6 headache (dizziness, nausea), 7 anosmia, and ageusia. 8 …”
Section: Introductionmentioning
confidence: 99%
“…Of particular interest, patients infected with SARS-CoV-2 have exhibited neurological symptoms such as headache, paresthesia, anosmia, dyslexia, ataxia, and alterations in mental status. 2 , 3 , 4 , 5 , 6 , 7 , 8 Additionally, the early stages of SARS-CoV-2 infection have been associated with transient structural abnormalities in the brain, 9 neuroinflammatory events, 2 , 3 , 4 , 5 and sensory loss such as anosmia. 8 Recent cases have reported the emergence of Parkinsonism in COVID-19 patients either during or shortly after SARS-CoV-2 infection, presenting symptoms such as rigidity, resting tremor in the upper extremities, and bradykinesia.…”
Section: Introductionmentioning
confidence: 99%